JAN 03, 2021 3:31 PM PST

How Psychedelic Salvinorin A Works in the Brain

WRITTEN BY: Annie Lennon

Despite increasing interest in hallucinogens, the effects of Salvinorin A, a drug used in Native Mexican rituals, have remained unknown. Now, however, researchers from Johns Hopkins University have conducted research on the drug's strength and general effects. 

Salvinorin A is a compound found in a plant called Salvia divinorum and is considered a dissociative hallucinogen. It produces out-of-body and amnesia-like experiences lasting up to 30 minutes. 

For the study, the researchers recruited 12 men aged between 23 and 52. Each was examined via functional magnetic resonance imaging (fMRI) on two occasions- one in which they inhaled Salvinarin A crystals (15 µg/kg), and another in which they inhaled a placebo. 

Altogether, the researchers examined activity in eight brain networks. Three were involved in vision, and five were for moving and touch, paying attention, and activating the default mode network while the mind rests. 

All in all, the researchers found that the default mode network decreased in synchronization, meaning signals in this area became more random and unpredictable. They also observed increased communication between brain networks while on the drug in comparison to the placebo.  

While participants generally reported their experiences to peak in intensity at 2 minutes in, they reported them to drop by approximately a half within 10 minutes. At 45 minutes, the experience had practically finished. 

"Salvinorin A seems to do all the things that researchers believe happen when other psychedelics (such as LSD and psilocybin) act on the brain," says Manoj Doss, Ph.D. one of the study's authors.

"The funny thing is that some researchers have selectively focused on the default mode network when that's not even where they find the strongest effects of classic psychedelics. In contrast, that is, in fact, where we found the strongest effects of salvinorin A."

The researchers now hope to compare their findings with brain imaging studies on other hallucinogenic drugs.

 

Sources: Neuroscience NewsNature

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 29, 2020
Cardiology
Treating Cardiovascular Calcification at the Source
OCT 29, 2020
Treating Cardiovascular Calcification at the Source
The term cardiovascular disease covers a broad array of health problems. Everyone tends to think of heart attacks or hyp ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
DEC 10, 2020
Immunology
Drug Turns Back the Clock in Aged Brains
DEC 10, 2020
Drug Turns Back the Clock in Aged Brains
When faced with stressful stimuli — anything from oxygen or nutrient deprivation to viral infections — cells ...
DEC 28, 2020
Immunology
Inhaling a Puff of Llama Antibodies to Relieve COVID
DEC 28, 2020
Inhaling a Puff of Llama Antibodies to Relieve COVID
Scientists at the National Institutes of Health have identified new antibody-based weapons in the fight against COVID-19 ...
Loading Comments...